Exosome-transmitted HSPA9 facilitates bortezomib resistance by targeting TRIP13/USP1 signaling in multiple myeloma
Abstract Background Resistance to the proteasome inhibitor bortezomib (BTZ) poses a formidable therapeutic challenge in multiple myeloma (MM). Our study aims to analyze the mechanism by which exosomes heat shock 70 kDa protein 9 (HSPA9) secreted by BTZ-resistant MM cells disseminate resistance to BT...
Saved in:
| Main Authors: | Min Shi, Na Shen, Xiangyu Liu, Jiapei Yu, Xuxing Shen, Ying Chen, Yuan Xia, Lijuan Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Cell Communication and Signaling |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12964-025-02158-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative IP-MS Reveals HSPA5 and HSPA8 Interacting with Hemagglutinin Protein to Promote the Replication of Influenza A Virus
by: Xingwei Feng, et al.
Published: (2025-05-01) -
NRF3 suppresses squamous carcinogenesis, involving the unfolded protein response regulator HSPA5
by: Selina Gurri, et al.
Published: (2023-10-01) -
RBMS1-HSPA8 axis activation drives head and neck squamous cell carcinoma progression
by: Xinghong Yin, et al.
Published: (2025-03-01) -
Results of multiple myeloma treatment with bortezomib
by: T. I. Pospelova, et al.
Published: (2022-11-01) -
Preparation of sightseeing trip text and elaboration of methodical development of such trip (on the example of the city of Chernivtsi
by: Oleksandr Korol, et al.
Published: (2024-08-01)